Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

20

Revenue 2017

Triumeq

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Triumeq was produced by GlaxoSmithKline.

ViiV bags US approval for HIV blockbuster-in-waiting

ViiV bags US approval for HIV blockbuster-in-waiting Triumeq combines ViiV's antiretroviral stalwarts lamivudine and abacavir with its brand new integrase inhibitor Tivicay (dolutegravir), which was approved in the US last August and in Europe in January. ... have suggested combination tablets such as

Biosimilar Lantus leads CHMP opinions

Biosimilar Lantus leads CHMP opinions Triumeq – a combination of already-approved treatments Tivicay (dolutegravir) and Kivexa (abacavir/lamivudine) – was recommended to treat HIV infection in adults and adolescents aged 12 years and older.

[ Previous 5 results ] 3 4 5 6 7

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics